Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.
Back to Politics
Politics
September 28, 2026 at 12:23 PM
Novo Nordisk's next-gen weight loss drug outperforms Zepbound in new trial
The Hill Home News
Excerpt from The Hill Home News.